AnaptysBio, Inc. (ANAB)
48.10
+0.16
(+0.33%)
USD |
NASDAQ |
Oct 22, 16:00
48.10
0.00 (0.00%)
After-Hours: 20:00
AnaptysBio Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -206.9% |
| December 31, 2025 | 45.83% |
| September 30, 2025 | 19.80% |
| June 30, 2025 | -173.5% |
| March 31, 2025 | -141.6% |
| December 31, 2024 | -50.53% |
| September 30, 2024 | -109.4% |
| June 30, 2024 | -425.3% |
| March 31, 2024 | -612.0% |
| December 31, 2023 | -468.8% |
| September 30, 2023 | -1.12K% |
| June 30, 2023 | -1.15K% |
| March 31, 2023 | -3.22K% |
| December 31, 2022 | -388.0% |
| September 30, 2022 | -2.59K% |
| June 30, 2022 | -2.68K% |
| March 31, 2022 | -3.74K% |
| December 31, 2021 | -3.22K% |
| September 30, 2021 | -31.91% |
| June 30, 2021 | -1.43% |
| March 31, 2021 | -161.5% |
| December 31, 2020 | 56.08% |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | -55.08% |
| Date | Value |
|---|---|
| December 31, 2019 | -675.4% |
| September 30, 2019 | |
| June 30, 2019 | -479.2% |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | -319.2% |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | -228.7% |
| September 30, 2017 | |
| June 30, 2017 | -38.34% |
| March 31, 2017 | |
| December 31, 2016 | -154.6% |
| September 30, 2016 | 0.00% |
| June 30, 2016 | 15.18% |
| March 31, 2016 | -18.25% |
| December 31, 2015 | -86.63% |
| September 30, 2015 | -32.22% |
| June 30, 2015 | -1.13% |
| March 31, 2015 | -9.18% |
| December 31, 2014 | -1.54% |
| September 30, 2014 | 11.65% |
| June 30, 2014 | 18.22% |
| March 31, 2014 | -66.98% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Agenus, Inc. | -1.64% |
| Amgen, Inc. | 23.59% |
| Anika Therapeutics, Inc. | 10.15% |
| BioCryst Pharmaceuticals, Inc. | 35.92% |
| Imunon, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | 69.74% |
| Return on Invested Capital | 79.47% |
| Return on Net Operating Assets | 475.6% |